Reboxetine plus Oxybutynin for Obstructed Sleep Apnea Treatment A 1-week Randomized, Placebo-controlled, Double-Blind Crossover Trial

MLA

Perger, E., et al. Reboxetine plus Oxybutynin for Obstructed Sleep Apnea Treatment A 1-Week Randomized, Placebo-Controlled, Double-Blind Crossover Trial. 2022. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1308940487&authtype=sso&custid=ns315887.

APA

Perger, E., Montemurro, L., Rosa, D., Vicini, S., Marconi, M., Zanotti, L., Meriggi, P., Azarbarzin, A., Sands, S., Wellman, A., Lombardi, C., Parati, G., Perger, E., Montemurro, L. T., Rosa, D., Vicini, S., Marconi, M., Zanotti, L., Meriggi, P., … Parati, G. (2022). Reboxetine plus Oxybutynin for Obstructed Sleep Apnea Treatment A 1-week Randomized, Placebo-controlled, Double-Blind Crossover Trial.

Chicago

Perger, E, L Montemurro, D Rosa, S Vicini, M Marconi, L Zanotti, P Meriggi, et al. 2022. “Reboxetine plus Oxybutynin for Obstructed Sleep Apnea Treatment A 1-Week Randomized, Placebo-Controlled, Double-Blind Crossover Trial.” http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1308940487&authtype=sso&custid=ns315887.